Abstract. suppresses the labeling of messenger RNA in HeLa cells. The drug has no effect on either the labeling of nuclear heterogeneous RNA or on the transport of messenger RNA into the cytoplasm. The results suggest that messenger RNA and nuclear heterogeneous RNA are synthesized separately, and that the transcription of messenger RNA is inhibited by the drug.
The nuclei of metazoan cells contain giant heterogeneous RNA. This species constitutes a major fraction of the RNA labeled during a pulse and turns over rapidly.5 Its function remains to be defined.
Some properties of the heterogeneous nuclear RNA (HnRNA) resemble those expected of cytoplasmic messenger RNA (mRNA). It is heterogeneous in size, its G + C content resembles that of cellular DNA, and it apparently hybridizes to a considerable fraction of the genome (J. E. Darnell, personal communication). However, a closer examination shows that HnRNA is actually quite different from mRNA found on polyribosomes. HnRNA ranges in sedimentation values from 10 S to greater than 200 S and is much larger than the mRNA found on cytoplasmic polyribosomes (8 S-30 S).6 While mRNA is found on polyribosomes in the cytoplasm, HnRNA is confined to the nucleus where no proteinsynthesizing structures have been found, at least after cell fractionation. The rate of labeling of HnRNA is much greater than that of cytoplasmic mRNA.
One hypothesis that attempts to reconcile the disparate properties of these RNA species postulates that HnRNA is a precursor to cytoplasmic mRNA and that a small region of the large molecule is cleaved and exported to the cytoplasm.7 However, the kinetics of labeling of HnRNA and mRNA are very different and do not seem to support a simple precursor-product relation6 although conclusions drawn from such measurements are far from compelling.
The experiments reported here also suggest that mRNA is not derived by cleavage from HnRNA, but rather is synthesized separately. Cordycepin, 3'-deoxyadenosine, a drug that appears to act primarily by interfering with transcription, selectively suppresses the labeling of cytoplasmic mRNA while it does not affect that of HnRNA.
Materials and Methods. Cell culture: HeLa cells were grown in suspension culture in Eagle's medium as described.8 The cell density was 4 X 105 cells/ml during growth and 2 X 106 cells/ml during labeling.
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Cell labeling and fractionation: Ribosomal RNA synthesis was suppressed by treating cells for 30 min before labeling with 0.04 ug/ml of actinomycin D. This concentration of actinomycin inhibits ribosome formation completely while having only minor effects on other RNA synthesis.6'9'10 Where whole cytoplasm was extracted, mitochondrial RNA synthesis was suppressed by the addition of 1 Ag/ml of ethidium bromide with the actinomvcin."1 Mitochondrial-specific RNA sediments in sucrose gradients in a region from 12 S to 20 S and could make a significant contribution to cytoplasmic messenger RNA.
Where indicated, cytoplasmic extracts were prepared by harvesting, washing, and resuspending cells in 1 ml of hypotonic buffer (10 mM NaCl, 1.5 mM MgC12, 10 Results. Messenger RNA has been identified by isolating polyribosomes from cytoplasmic extracts and examining the RNA associated with them.6"3 In the present experiments, the messenger-like RNA from total cytoplasmic extracts, as well as RNA associated with polyribosomes, was measured in order to show that the effect of cordycepin is to suppress labeling of all messenger-like RNA, and not simply to prevent it from associating with polyribosomes.
The identification of messenger-like RNA in total cytoplasmic extracts is shown in Fig. 1 . The labeled RNA extracted from polyribosomes sediments in the 8-30 S region of a sucrose gradient. When polyribosomes are disrupted with EDTA prior to sedimentation, the 8-30S RNA is no longer found in the polyribosome region of the sucrose gradient. In contrast, the "flat-background" RNA (RNA that remains after EDTA treatment of the polyribosomes; see 1 ) is still found in the polyribosome region, apparently associated with an EDTA-resistant structure. 6 The specific association of the EDTA-sensitive material with polyribosomes has been demonstrated in several ways.6' 13 The labeled RNA from total cytoplasmic extracts is also shown in Fig. 1 . Most of this RNA sediments with the 8-30S distribution characteristic of mRNA isolated from polyribosomes. Both the size distribution ( Fig. 1 ) and the sensitivity to cordycepin (see below) of the messenger-like RNA from total cytoplasm and mRNA isolated from polyribosomes cannot be distinguished. In all of these experiments, ribosomal RNA synthesis was suppressed with low concentrations of actinomycin4'6'9 permitting labeling of mRNA for long periods of time.
mRNA constitutes only a small fraction of the cytoplasmic RNA; its synthesis is soon obscured if synthesis of ribosomal RNA is permitted. Where noted, high molecular weight RNA was purified from 4S RNA by precipitation with 2 M NaCl.
It has been shown that cordycepin prevents formation of completed ribosomal RNA precursors and causes production of small pieces of RNA in the nucleolus.'4 Recent investigations (to be reported elsewhere) have shown that cordycepin inhibits mitochondrial RNA synthesis without the production of short pieces.'- Fig. 2 shows the distribution of RNA in the nucleus and cytoplasm of cells labeled for different times in the presence and absence of cordycepin.-The HnRNA appears unaffected, either in amount or size. The small differences in the amount of labeled RNA between treated and untreated nuclear samples represent the reproducibility of this RNA preparation and are not systematic. The labeling of most of the cytoplasmic RNA of 8-30 S is suppressed, but a background remains. The distribution of this "background" RNA resembles that of the EDTA-insensitive material that is apparently not mRNA; it is presumably either another type of cytoplasmic heterogeneous RNA or it is RNA that has leaked from the nucleus.
Messenger RNA may also be identified by its association with structures having the buoyant density of polyribosomes in CsCl."3 Ribosomes were labeled overnight with ["C ]uridine, then heterogeneous RNA was labeled for 90 min with [3Hjuridine in the presence of actinomycin. Polyribosomes were prepared by sucrose density gradient centrifugation of cytoplasmic extracts. Fractions corresponding to the polyribosome region were then combined, fixed with glutaraldehyde, and centrifuged to equilibrium in CsCl density gradients. '6 The results are shown in Fig. 3 . The "4C-labeled RNA, which is principally ribosomal, is found in a slightly asymmetric peak (density 1.54 g/cm3), while the pulse-labeled RNA is in two peaks. The pulse-labeled peak of greater density is nearly coincident with the ribosomal marker and the second, minor peak has a density corresponding to nonpolyribosomal RNA with associated protein. The 3H-labeled mRNA peak is skewed to the lower density side of the ribosome peak. The lack of coincidence of the 'H-labeled mRNA peak with the 14C-labeled ribosome peak has been noted before and may be due to the contribution of mRNA, which is lightly loaded with ribosomes and coated with adventitious protein. Cordycepin greatly reduces the amount of 3H-labeled RNA associated with polyribosomes while not affecting the amount of nonribosomal 3H-labeled RNA. Fig. 1 . 25 ,ug/ml cordycepin was added to onehalf the culture. After 30 min, 150 A Ci of [3H] uridine, diluted with 0.22 mg of unlabeled uridine was added to each culture. Samples were taken 40, 90, and 180 min later. Cells were broken in a Dounce homogenizer and nuclei were purified and digested. RNA was analyzed on sodium dodecyl sulfate-sucrose gradients centrifuged for 2 hr at 40,000 rpm in the SW40 rotor. (Right) Messenger RNA: Treatment of the cells was as in "left" except that cytoplasmic extract was made with NP40. RNA was extracted with phenol-sodium dodecyl sulfate, precipitated with 2 M NaCl, and centrifuged as in Fig. 1 Experiments of this type cannot determine whether cordycepin acts on transcription or interferes with the transport of mRNA from its site of synthesis to the cytoplasm. However, it can be shown that the inhibition by cordycepin occurs at about the same time as transcription, and that later steps between synthesis and the appearance of mRNA in the cytoplasm are insensitive to this agent.
There is a lag of about 15 min between the addition of labeled RNA precursor to cells and the appearance of labeled mRNA on polyribosomes.6 The sedimentation profiles of labeled RNA from total cytoplasm shown in Fig. 4 indicate that the appearance of mRNA in total cytoplasm occurs with the same lag. After 15 min of labeling, only the flat distribution of heterogeneous RNA is seen. By 30 min, the S-30S distribution, characteristic of mRNA, is seen. Subsequently, the amount of mRNA continues to increase in a nearly linear fashion.
The supply of mRNA can be demonstrated another way. A culture was labeled with uridine for 15 min in the presence of a low concentration of actinomycin. All new RNA synthesis was then inhibited by the addition of actinomycin at a high concentration, and incubation was continued for another 15 min. Fig. 5 shows that after 15 min of labeling, only the flat distribution of heterogeneous RNA is present. Actinomycin does not interfere with the emergence of the 8-30S mRNA for the next 15 min. Subsequently, appearance of RNA in the cytoplasm ceases as reported for mRNA measured on polyribosomes.6 Thus, there is a 15-20 min supply of mRNA in the nucleus, and its subsequent appearance in the cytoplasm is independent of continuing RNA synthesis.
Since mRNA continues to emerge into the cytoplasm in the presence of actinomycin, it should be possible to determine whether cordycepin interferes with the Actinomycin, 5 ,g/ml, was added to the remainder of the culture; incubation was continued for 15 min. Cytoplasm was prepared with NP40.13 RNA was extracted with phenol, precipitated with 2 M NaCl, and analyzed as in Fig. 1 . 0-C, no actinomycin; 0-4, actinomycin, 15min.
emergence of a preexisting supply ol mRNA. Fig. 6A shows the cytoplasmic RNA from cells labeled for 20 min and incubated an additional 25 min in the presence of 5 pig/ml of actinomycin. Cordycepin was added to one-half of the culture at the same time as the high concentration of actinomycin. Addition of the drug does not affect the amount of mRNA which appears during the next 25min.
If cordycepin acts at or close to the site of transcription, and if there is no appreciable lag before its effect is manifested, then addition of cordycepin simultaneously with labeled uridine should prevent the appearance of mRNA. This is shown in Fig. 6B , in which prior or simultaneous addition of cordycepin with the uridine effectively suppresses the subsequent appearance of the 8-30S mRNA. If cordycepin is added 10 min after labeling of RNA commences, and actinomycin is added at 20 min, then one-half of the amount of mRNA in the untreated sample should appear. This prediction is confirmed by Fig. 6B . An unambiguous interpretation of the results in Fig. 6B requires that cordycepin act without appreciable lag. Since the nucleolus ceases to form 45S RNA within 3 min of administration of the drug, at least the initial manifestations of cordycepin action occur promptly. p sg/ml with respect to actinomycin and cordycepin, respectively. The cultures were harvested after 25min. Cytoplasmic extract was made as described in Fig. 2 (left) and extracted and centrifuged as in Fig. 1 The differing responses of RNA synthesis to cordycepin suggest the existence of several distinct polymerases in the mammalian cell. This suggestion must be considered speculative, however, since the basis for the different reactions to the drug are not known. The complete insensitivity of the HnRNA to cordycepin might also raise a question about the nature of these molecules, which have not been well characterized. For example, in the unlikely event that HnRNA possessed a 5'-2' phosphodiester linkage, its snythesis might be insensitive to the drug. However, the synthesis of poliovirus RNA, which has been well characterized, is also insensitive to cordycepin. Thus, there is at least one RNA polymerase, albeit one primed by RNA, that makes a normal 5'-3' product and is insensitive to the drug.
The results suggest that HnRNA and mRNA are transcribed by two enzy.mes with different sensitivities to cordycepin. However, in lieu of a direct demonstration of separate enzymes, this conclusion is subject to some reservation. The experiments do not rule out the possibility of interference by the drug with a step immediately after transcription. However, the lack of interference with the emergence of mRNA from the nucleus shows that cordycepin does not inhibit the transport of mRNA after transcription.
